is tirzepatide same as glp 1 Molecular structure of and the dual activation mechanism of Effects of tirzepatide, a dual

The STEP 1 trial found that people taking 2.4 mg of semaglutide weekly lost an average of 15% of their body weight over about 16 months

If the data shows a clear response plateau at 4mg, that signals that a higher dose would likely provide additional benefit

(Source: AJMC, July 2026) Which Symptoms Actually Drive Discontinuation In longer-term trials that broke out individual adverse event categories, nausea was the leading cause of discontinuation , followed by vomiting and diarrhoea

Dosing typically begins at a lower dose and may be adjusted over time based on your clinicians judgment and your individual response

Efficacy and safety of GLP-1 medicines for type 2 diabetes and obesity

Looking for alternatives